6DEC - JANTECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe realm of medical research has evolved into one that moves exceedingly quickly, evolving through technology and process innovation. The need to provide accurate results quickly and easily has never been greater due to the ever-increasing demand. This is especially true for pharmaceutical research, as preferred methodologies have shifted towards finding novel, evidence-based drugs. Interdisciplinary collaboration, cutting-edge technologies, and a more streamlined approach focused on making new and effective treatments available to patients as quickly as possible is the new target that all pharma contract research organizations (CRO) are vying for.Through the devoted use of technology and an organizational structure designed to consistently complete contractual tasks, CROs provide an unmatched capacity to work to high standards. The current marketplace is with rife with specialized CROs capable of reliably moving a novel medication or device from its inception to FDA/EMA marketing clearance. They also perform more complex tasks revolving around tissue engineering, pharmacokinetics, pharmacodynamics, and biocompatibility. In this Pharma Tech Outlook edition, we present some of the most prominent Canada Contract Research Organizations Companies. The issue features thought leadership articles from Alexander Bernikov, Medical Director, Clinical Development (Uro)-Oncology, Jiangsu Hengrui Pharmaceuticals, Philippe Marc, Executive Director, Global Head of Integrated Data Science, Novartis, and Iris Loew-Friedrich, EVP & Chief Medical Officer, UCB. The edition also showcases innovative solutions from Cliantha, a full-service CRO with eighteen years of accumulated expertise in early phase (BA/BE), respiratory studies, tobacco research, dermatology, consumer research, analytical lab, diagnostic central lab, IVRT, IVPT, Biometrics, environmental exposure chambers and medical services.Leafing through these pages will give you comprehensive insights into the different CROs in Canada that are transforming the pharmaceutical industry with innovative services.Fostering Innovations in the Pharmaceutical LandscapeCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - JANUARY, Vol 08 - Issue 23 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Disclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsEditor-in-ChiefStacey SmithVisualizerRonald DonovanMichael WayneEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul Barbersales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:TECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >